Literature DB >> 34648637

Low Sensitivity of Rapid Antigen Tests to Detect Severe Acute Respiratory Syndrome Coronavirus 2 Infections Before and on the Day of Symptom Onset in Nursing Home Staff and Residents, Germany, January-March 2021.

Jennifer K Bender1,2, Emily D Meyer3,4, Mirco Sandfort3,4, Dorothea Matysiak-Klose5, Gerhard Bojara6, Wiebke Hellenbrand5.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34648637      PMCID: PMC8524645          DOI: 10.1093/infdis/jiab528

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
To the Editor—We read with interest the recent article by Smith et al [1], comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapid antigen detection tests (RADTs) with reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Our observations obtained during a SARS-CoV-2 outbreak in a nursing home add further evidence regarding the reliability of RADTs. RADTs provide a timely, easy-to-use, and crucial tool for detecting SARS-CoV-2 [2]. Thus, they are widely applied for routine screening at workplaces [3]. However, RADTs have a lower sensitivity than RT-qPCR [4]. Because RADTs were mostly validated in symptomatic cases, data on the sensitivity of RADTs when testing presymptomatic SARS-CoV-2 infections are limited [4, 5]. This is of great importance, however, because infectiousness is highest in the days before and around the time of symptom onset [6, 7]. Furthermore, presymptomatic transmission accounts for a substantial proportion of secondary cases [8]. In a cohort of RT-qPCR–confirmed SARS-CoV-2 alpha cases related to an outbreak in a nursing home in Germany in January–March 2021, we analyzed the sensitivity of a commercial RADT and of RT-qPCR, including 2 days before as well as the day of symptom onset (“reference period”). Nasopharyngeal samples were used for both RADTs and RT-qPCR and were collected by nursing home staff or external health professionals. RADTs were performed daily on staff, while residents were tested as needed (eg, after contact with a case). Furthermore, we assessed the association between a positive test result (RADT or RT-qPCR) and status (staff or resident), using the Fisher exact test. Owing to multiple tests per person within the reference period, 35 RADT results were available from 18 individuals with coronavirus disease 2019 (8 residents and 10 staff; Table 1). Ten of the 35 RADTs had positive results (29% [95% confidence interval (CI), 15%–46%]). Remarkably, 6 of 8 RADTs (75%) performed on the day of symptom onset had negative results. Summarizing the results of all tests performed per case, RADTs identified 9 of 18 cases (50%) (8 of 8 residents [100%] and 1 of 10 staff [10%]). For RT-qPCR, 19 individual results were available (14 residents and 5 staff). Note that individuals who underwent RADTs did not necessarily undergo PCR within the reference period, and vice versa. RT-qPCR was performed only once for each case within the reference period and identified 17 of 19 cases (90% [95% CI, 67%–99%]; 13 of 14 residents [93%] and 4 of 5 staff [80%]). RT-qPCR results did not differ between residents and staff (P = .46), but staff were less likely than residents to have a positive RADT result (1 of 24 vs 9 of 11, respectively; P < .01).
Table 1.

Test Results in Samples Obtained at and Before Symptom Onset From Nursing Home Staff and Residents Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in an Alpha Variant Outbreak, Germany, January–March

TestSamples by Test Result, No. (%)a
Day 0Day −1Day −2Total
PositiveNegativePositiveNegativePositiveNegativePositiveNegative
RADTb2 (25)6 (75)1 (10)9 (90)7 (41)10 (59)10 (29)25 (71)
 Staff1 (14)6 (86)08 (100)09 (100)1 (4)23 (96)
 Residents1 (100)01 (50)1 (50)7 (88)1 (12)9 (82)2 (18)
RT-qPCRc5 (100)09 (90)1 (10)3 (75)1 (25)17 (90)2 (10)
 Staff3 (100)0001 (50)1 (50)4 (80)1 (20)
 Residents2 (100)09 (90)1 (10)2 (100)013 (93)1 (7)

Abbreviations; RADT, rapid antigen detection test; RT-qPCR, reverse-transcription quantitative polymerase chain reaction.

Percentages are row percentages for each day. Day 0 was the day of symptom onset; days −1 and −2, the presymptomatic period.

RADTs were repeatedly performed within the reference period (35 results were available from 18 cases).

RT-qPCR was performed only once for each case within the reference period (19 results available from 19 cases); note that RT-qPCR and RADT results are not necessarily derived from the same individuals and thus represent different study populations.

Test Results in Samples Obtained at and Before Symptom Onset From Nursing Home Staff and Residents Positive for Severe Acute Respiratory Syndrome Coronavirus 2 in an Alpha Variant Outbreak, Germany, January–March Abbreviations; RADT, rapid antigen detection test; RT-qPCR, reverse-transcription quantitative polymerase chain reaction. Percentages are row percentages for each day. Day 0 was the day of symptom onset; days −1 and −2, the presymptomatic period. RADTs were repeatedly performed within the reference period (35 results were available from 18 cases). RT-qPCR was performed only once for each case within the reference period (19 results available from 19 cases); note that RT-qPCR and RADT results are not necessarily derived from the same individuals and thus represent different study populations. Our study is limited by its small sample size. We had too few observations to investigate the effect of vaccination or the day of testing relative to symptom onset. Furthermore, we could not directly compare RT-qPCR and RADT results because the study populations differed. In line with the higher sensitivity of RT-qPCR relative to RADTs in the early infectious period, as described by Smith et al [1], our analyses show that RT-qPCR identified cases before or on the day of symptom onset more reliably than RADTs. Only 29% of all RADTs performed within the reference period yielded a true-positive result, even though high viral loads are expected at this time [6, 9]. Our results are also in accordance with a recent Cochrane review, which demonstrated a low sensitivity of 58.1% (95% CI, 40.2%–74.1%) for RADTs in asymptomatic, PCR-confirmed SARS-CoV-2 cases [5]. However, that review did not assess sensitivity in presymptomatic cases. We observed a higher proportion of positive RADTs among residents than among staff. In contrast, the sensitivity of RT-qPCR was similar in both groups. For RT-qPCR, health workers from outside the nursing home performed the sampling. For the RADTs, swab samples were obtained by nursing home staff, and it was reported that they were well trained and that sampling was performed similarly for staff and residents. Nonetheless, sampling differences, such as hesitancy to perform deep swabbing on colleagues, cannot be ruled out and could explain the lower sensitivity among staff. Likewise, sampling differences could partially explain the higher sensitivities found by Smith et al [1], in a study where study staff collected the samples. As highlighted in our study, RADT sensitivity is low before and on the day of symptom onset. Even with increased test frequency, sensitivity reached only 50%. This is particularly worrisome in the light of a decision adopted by the German federal government and Länder (federal states) on 23 August 2021 to permit social gatherings (eg, visits to mass events) with a single negative RADT result <24 hours old [10]. A negative RADT result must be interpreted cautiously, and nonpharmaceutical preventative measures must remain implemented, especially among vulnerable groups. We obtained our results during an outbreak investigation conducted as part of the official tasks of the respective district’s. Local public health authorities, supported by the Robert Koch Institute on official request in accordance with section 4 of the German Protection Against Infection Act. This investigation was therefore exempt from additional institutional review.
  7 in total

1.  Rethinking Covid-19 Test Sensitivity - A Strategy for Containment.

Authors:  Michael J Mina; Roy Parker; Daniel B Larremore
Journal:  N Engl J Med       Date:  2020-09-30       Impact factor: 91.245

2.  Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.

Authors:  Jacqueline Dinnes; Jonathan J Deeks; Sarah Berhane; Melissa Taylor; Ada Adriano; Clare Davenport; Sabine Dittrich; Devy Emperador; Yemisi Takwoingi; Jane Cunningham; Sophie Beese; Julie Domen; Janine Dretzke; Lavinia Ferrante di Ruffano; Isobel M Harris; Malcolm J Price; Sian Taylor-Phillips; Lotty Hooft; Mariska Mg Leeflang; Matthew Df McInnes; René Spijker; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2021-03-24

3.  Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

Authors:  Melissa M Arons; Kelly M Hatfield; Sujan C Reddy; Anne Kimball; Allison James; Jesica R Jacobs; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Jonathan W Dyal; Josh Harney; Zeshan Chisty; Jeneita M Bell; Mark Methner; Prabasaj Paul; Christina M Carlson; Heather P McLaughlin; Natalie Thornburg; Suxiang Tong; Azaibi Tamin; Ying Tao; Anna Uehara; Jennifer Harcourt; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Patty Montgomery; Nimalie D Stone; Thomas A Clark; Margaret A Honein; Jeffrey S Duchin; John A Jernigan
Journal:  N Engl J Med       Date:  2020-04-24       Impact factor: 91.245

4.  Author Correction: Temporal dynamics in viral shedding and transmissibility of COVID-19.

Authors:  Xi He; Eric H Y Lau; Peng Wu; Xilong Deng; Jian Wang; Xinxin Hao; Yiu Chung Lau; Jessica Y Wong; Yujuan Guan; Xinghua Tan; Xiaoneng Mo; Yanqing Chen; Baolin Liao; Weilie Chen; Fengyu Hu; Qing Zhang; Mingqiu Zhong; Yanrong Wu; Lingzhai Zhao; Fuchun Zhang; Benjamin J Cowling; Fang Li; Gabriel M Leung
Journal:  Nat Med       Date:  2020-09       Impact factor: 53.440

5.  Analysis of Asymptomatic and Presymptomatic Transmission in SARS-CoV-2 Outbreak, Germany, 2020.

Authors:  Jennifer K Bender; Michael Brandl; Michael Höhle; Udo Buchholz; Nadine Zeitlmann
Journal:  Emerg Infect Dis       Date:  2021-02-18       Impact factor: 6.883

6.  Longitudinal Assessment of Diagnostic Test Performance Over the Course of Acute SARS-CoV-2 Infection.

Authors:  Rebecca L Smith; Laura L Gibson; Pamela P Martinez; Ruian Ke; Agha Mirza; Madison Conte; Nicholas Gallagher; Abigail Conte; Leyi Wang; Richard Fredrickson; Darci C Edmonson; Melinda E Baughman; Karen K Chiu; Hannah Choi; Tor W Jensen; Kevin R Scardina; Shannon Bradley; Stacy L Gloss; Crystal Reinhart; Jagadeesh Yedetore; Alyssa N Owens; John Broach; Bruce Barton; Peter Lazar; Darcy Henness; Todd Young; Alastair Dunnett; Matthew L Robinson; Heba H Mostafa; Andrew Pekosz; Yukari C Manabe; William J Heetderks; David D McManus; Christopher B Brooke
Journal:  J Infect Dis       Date:  2021-09-17       Impact factor: 7.759

7.  Estimating infectiousness throughout SARS-CoV-2 infection course.

Authors:  Terry C Jones; Guido Biele; Barbara Mühlemann; Talitha Veith; Julia Schneider; Jörn Beheim-Schwarzbach; Tobias Bleicker; Julia Tesch; Marie Luisa Schmidt; Leif Erik Sander; Florian Kurth; Peter Menzel; Rolf Schwarzer; Marta Zuchowski; Jörg Hofmann; Andi Krumbholz; Angela Stein; Anke Edelmann; Victor Max Corman; Christian Drosten
Journal:  Science       Date:  2021-05-25       Impact factor: 63.714

  7 in total
  2 in total

Review 1.  Diagnostic Approaches For COVID-19: Lessons Learned and the Path Forward.

Authors:  Maha Alafeef; Dipanjan Pan
Journal:  ACS Nano       Date:  2022-08-03       Impact factor: 18.027

2.  BNT162b2 vaccination reduced infections and transmission in a COVID-19 outbreak in a nursing home in Germany, 2021.

Authors:  Emily Dorothee Meyer; Mirco Sandfort; Jennifer Bender; Dorothea Matysiak-Klose; Achim Dörre; Gerhard Bojara; Konrad Beyrer; Wiebke Hellenbrand
Journal:  Influenza Other Respir Viruses       Date:  2022-09-09       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.